Clover Health Investments Corp [NASDAQ: CLOV] closed the trading session at $3.69.
The stocks have a year to date performance of 17.14 percent and weekly performance of 8.53 percent. The stock has been moved at 19.81 percent over the last six months. The stock has performed 11.14 percent around the most recent 30 days and changed -18.90 percent over the most recent 3-months.
If compared to the average trading volume of 6.10M shares, CLOV reached to a volume of 5380016 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Clover Health Investments Corp [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $4.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Clover Health Investments Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 17, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Neutral. The new note on the price target was released on October 07, 2024, representing the official price target for Clover Health Investments Corp stock. Previously, the target price had yet another drop from $7 to $3, while Cowen kept a Market Perform rating on CLOV stock.
The Average True Range (ATR) for Clover Health Investments Corp is set at 0.19, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 1.26. The Price to Book ratio for the last quarter was 5.28.
CLOV stock trade performance evaluation
Clover Health Investments Corp [CLOV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.53. With this latest performance, CLOV shares gained by 11.14% in over the last four-week period, additionally plugging by 19.81% over the last 6 months – not to mention a rise of 295.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 57.07, with the RSI for the last a single of trading hit 62.08, and the three-weeks RSI is set at 53.87 for Clover Health Investments Corp [CLOV]. The present Moving Average for the last 50 days of trading for this stock 3.55, while it was recorded at 3.51 for the last single week of trading, and 3.51 for the last 200 days.
Clover Health Investments Corp [CLOV]: An insightful look at the core fundamentals
Clover Health Investments Corp’s liquidity data is similarly interesting compelling, with a Current Ratio set at 1.54.
Clover Health Investments Corp [CLOV]: Institutional Ownership
There are presently around $26.11%, or 27.15%% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 17.35 million shares, which is approximately 3.5581%. RENAISSANCE TECHNOLOGIES LLC, holding 11.27 million shares of the stock with an approximate value of $$13.86 million in CLOV stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$11.73 million in CLOV stock with ownership which is approximately 1.9568%.
